Marshall Wace’s Kezar Life Sciences KZR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-19,682
| Closed | -$61.6K | – | 2264 |
|
|
2023
Q1 | $61.6K | Buy |
19,682
+6,928
| +54% | +$21.7K | ﹤0.01% | 2028 |
|
|
2022
Q4 | $89.8K | Sell |
12,754
-645,686
| -98% | -$4.55M | ﹤0.01% | 2203 |
|
|
2022
Q3 | $5.67M | Sell |
658,440
-1,250,075
| -65% | -$10.8M | 0.01% | 1125 |
|
|
2022
Q2 | $15.8M | Buy |
1,908,515
+1,453,020
| +319% | +$12M | 0.03% | 530 |
|
|
2022
Q1 | $7.57M | Buy |
+455,495
| New | +$7.57M | 0.01% | 1000 |
|
|
2020
Q4 | – | Sell |
-43,196
| Closed | -$209K | – | 1906 |
|
|
2020
Q3 | $209K | Sell |
43,196
-38,654
| -47% | -$187K | ﹤0.01% | 1413 |
|
|
2020
Q2 | $423K | Buy |
+81,850
| New | +$423K | ﹤0.01% | 1216 |
|
|
2019
Q4 | – | Sell |
-32,523
| Closed | -$107K | – | 1853 |
|
|
2019
Q3 | $107K | Sell |
32,523
-20,493
| -39% | -$67.4K | ﹤0.01% | 1344 |
|
|
2019
Q2 | $409K | Buy |
53,016
+13,353
| +34% | +$103K | ﹤0.01% | 1095 |
|
|
2019
Q1 | $704K | Buy |
+39,663
| New | +$704K | 0.01% | 1030 |
|